Hypertrophic Cardiomyopathy 3 C1861863
An inherited condition where heart muscle thickening impairs pumping and may cause dangerous irregular heartbeats. Treatment aims to control symptoms and prevent sudden cardiac events.
Key facts at a glance
- ICD-10
- I78.0
- ICD-11
- BA00.0
- Body system
- cardiovascular
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Chest pain
Syncope
Chest discomfort or palpitations
(cardiovascular)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Dyspnea on exertion
(cardiovascular)Palpitations
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Beta-blocker therapy
Primary pharmacologic management using beta-adrenergic antagonists to control heart rate, reduce myocardial oxygen demand, and improve exercise tolerance. Therapy is initiated at low doses and titrated based on symptom response and heart rate.
Disease management and monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Ambulatory arrhythmia monitoring
Regular Holter monitoring and event recorders to detect paroxysmal atrial fibrillation, ventricular tachycardia, or other arrhythmias that may contribute to symptom progression or sudden cardiac death risk.
Additional treatment options
Alcohol septal ablation
Catheter-based technique for reducing dynamic outflow obstruction by selectively embolizing the first septal perforator branch. Indicated for patients with suitable anatomy who are poor surgical candidates or prefer less invasive approach.
procedureAvoidance of triggers
Education and counseling to identify and avoid triggers that may exacerbate symptoms, including extreme temperatures, dehydration, Valsalva maneuvers, and isometric exercises. Development of personalized activity plans with the care team.
lifestyleStress management techniques
Relaxation training, breathing exercises, and stress reduction strategies to help manage anxiety and reduce sympathetic activation that may worsen symptoms. Cognitive-behavioral approaches may be beneficial for coping with chronic illness.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Hypertrophic Cardiomyopathy 3 C1861863?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Hypertrophic Cardiomyopathy 3 C1861863. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy